No recent analyst price targets found for AIDX.
Latest News for AIDX
20/20 BioLabs Launches OneTest for Longevity Blood Test and Chronic Disease Risk Assessment and Management Solution Built with IBM AI Capabilities
Recently Nasdaq-Listed Company Introduces Longevity Blood Test Integrating Inflammatory Biomarkers, Dietary Habits, and Curated Scientific Research to Deliver Personalized Health Insights GAITHERSBURG, Md., Feb. 25, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs (Nasdaq: AIDX), an early market leader in cutting-edge, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases,…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for AIDX.
Senate Trading
No Senate trades found for AIDX.
U.S. House Trading
No House trades found for AIDX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.